NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268958. A total of 5 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $9,563,000 | – | 90,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 235 | $836,000 | 0.08% |
| GROUP ONE TRADING, L.P. | 131,800 | $4,689,000 | 0.04% |
| SIMPLEX TRADING, LLC | 677 | $2,408,000 | 0.01% |
| JPMORGAN CHASE & CO | 18,800 | $652,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |